ArticleNeurology and therapy2026

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

Wolfgang H Jost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.